What is the recommended dose of cloxacillin (antibiotic) for treating cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cloxacillin Dosing for Cellulitis

For non-purulent cellulitis in adults, the recommended dose of cloxacillin is 500 mg orally four times daily for 5 days, with extension if the infection has not improved within this time period. 1, 2

First-Line Treatment Options

  • Cloxacillin (dicloxacillin) 500 mg orally four times daily is a first-line treatment for typical, non-purulent cellulitis 1, 2
  • Other β-lactam alternatives include:
    • Cephalexin 500 mg orally four times daily 1, 2
    • Amoxicillin 500 mg orally three times daily 1
    • Amoxicillin-clavulanate 875/125 mg orally twice daily 2, 3
    • Penicillin (for known streptococcal infections) 1

Duration of Therapy

  • A 5-day course of antimicrobial therapy is as effective as a 10-day course for uncomplicated cellulitis if clinical improvement has occurred by day 5 1, 2, 3
  • Treatment should be extended if the infection has not improved within the initial 5-day period 2, 4
  • For severe infections with systemic symptoms or skin sloughing, longer courses (10-14 days) may be necessary 2, 5

Special Considerations

MRSA Coverage

  • Standard β-lactams like cloxacillin do not cover MRSA 1
  • Consider MRSA coverage only in specific situations:
    • Cellulitis associated with penetrating trauma 1, 3
    • Evidence of MRSA infection elsewhere 1, 3
    • Purulent drainage 1, 3
    • History of injection drug use 3
    • Failure to respond to β-lactam therapy 1

Severe Infections

  • For patients with systemic toxicity or rapidly progressive infection, intravenous therapy is recommended 1, 2
  • Hospitalization criteria include:
    • Severe infection with systemic inflammatory response syndrome 2, 3
    • Altered mental status or hemodynamic instability 2, 3
    • Concern for deeper or necrotizing infection 2
    • Immunocompromise 3
    • Failure of outpatient treatment 3

Adjunctive Measures

  • Elevation of the affected area to promote drainage of edema and inflammatory substances 1, 3
  • Identification and treatment of predisposing factors such as edema, obesity, eczema, venous insufficiency, and toe web abnormalities 2, 3
  • Consider systemic corticosteroids in non-diabetic adult patients to reduce inflammation and hasten resolution 2, 3, 6

Prevention of Recurrence

  • For patients with 3-4 episodes of cellulitis per year, consider prophylactic antibiotics 2, 3
  • Options include oral penicillin or erythromycin twice daily for 4-52 weeks, or intramuscular benzathine penicillin every 2-4 weeks 2, 3

Common Pitfalls to Avoid

  • Don't extend treatment unnecessarily beyond 5 days if clinical improvement has occurred 2, 4
  • Don't automatically add MRSA coverage for typical non-purulent cellulitis without specific risk factors 1, 3
  • Don't forget to examine interdigital toe spaces in lower-extremity cellulitis, as treating fissuring or maceration may reduce recurrence 3
  • Don't overlook the importance of elevating the affected area, especially in patients with venous insufficiency or lymphedema 1, 3
  • Be aware that allergic reactions to cloxacillin can occur, though cross-reactivity with other β-lactams like amoxicillin and cefuroxime may be uncommon 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Cellulitis in Adult Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Cellulitis in Older Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.